MetLife
MET
95.67
-1.93
-1.98%
MetLife
US · MET
#367 by market cap
Listed 2000
95.67
-1.93
-1.98%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Wells Fargo Maintains MetLife(MET.US) With Buy Rating, Raises Target Price to $113Market Newswire · 2026/11/12
-
Rating change
Wells Fargo Adjusts Price Target on MetLife to $113 From $110MT Newswires · 2026/11/12
-
Company notice
MetLife | 144: Notice of proposed sale of securities pursuant to Rule 144SEC · 2026/11/19
-
Company notice
MetLife | 144: Notice of proposed sale of securities pursuant to Rule 144SEC · 2026/11/20
-
J.P. Morgan Maintains MetLife(MET.US) With Buy Rating, Raises Target Price to $112Market Newswire · 2026/11/13
-
Rating change
CSPC Pharma (01093.HK): 3Q26 results met expectations; organic business showed steady upward momentum.CICC · 2026/11/19
-
Rating change
JPMorgan Adjusts Price Target on MetLife to $112 From $110MT Newswires · 2026/11/11
-
Wells Fargo Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $113Market Newswire · 2026/11/13
-
Rating change
Deutsche Bank Adjusts MetLife Price Target to $107 From $87, Maintains Hold RatingMT Newswires · 2026/11/10
-
Company notice
MetLife | 13F-HR: Information required of institutional investment managers pursuant to Section 13(f)SEC · 2026/11/17
-
Rating change
Mizuho Maintains Outperform on MetLife, Raises Price Target to $117Benzinga · 2026/11/12
-
Company notice
MetLife | 144: Notice of proposed sale of securities pursuant to Rule 144SEC · 2026/11/20
-
Press Release: MetLife Declares Fourth Quarter 2026 Preferred Stock DividendsDow Jones · 2026/11/17
-
Rating change
Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $113Benzinga · 2026/11/12
-
Rating change
Huatai Securities (601688): Fee-based businesses showed solid growth; overall performance met expectations.Huayuan Securities · 2026/11/12
-
Rating change
KBW Maintains MetLife(MET.US) With Buy Rating, Raises Target Price to $111Market Newswire · 2026/11/11
-
Rating change
MetLife Is Maintained at Overweight by Wells FargoDow Jones · 2026/11/12
-
Mizuho Securities Maintains MetLife(MET.US) With Buy Rating, Raises Target Price to $117Market Newswire · 2026/11/13
-
Company notice
MetLife | 4: Statement of changes in beneficial ownership of securities-Officer McCallion John D.SEC · 2026/11/21
-
MetLife(MET.US) Officer Sells US$19.3 Million in Common StockMarket Newswire · 2026/11/13
-
Rating change
UBS Maintains Warrior Met Coal(HCC.US) With Buy Rating, Cuts Target Price to $97Market Newswire · 2026/11/5
-
Company notice
MetLife | 10-Q: Quarterly reportSEC · 2026/11/6
-
Rating change
Melco International Development (00200.HK): 3Q26 results met consensus expectations; dividend resumption may be delayed.CICC · 2026/11/5
-
Rating change
Barclays Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $111Market Newswire · 2026/11/5
-
Rating change
Nomura Securities: MasMicro's Q3 results met expectations; maintained Buy rating but lowered target price.Gelonghui Finance · 2026/11/6
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
MetLife discussion 0 comments